title: Bone marrow involvement in systemic amyloidosis: another mechanism for erythropoietin resistance.
authors.forename: C
authors.initials: C
authors.lastname: Sungur
authors.forename: A
authors.initials: A
authors.lastname: Sungur
authors.forename: N
authors.initials: N
authors.lastname: Arik
authors.forename: T
authors.initials: T
authors.lastname: Akpolat
authors.forename: T
authors.initials: T
authors.lastname: Arinsoy
authors.forename: U
authors.initials: U
authors.lastname: Yasavul
authors.forename: C
authors.initials: C
authors.lastname: Turgan
authors.forename: S
authors.initials: S
authors.lastname: Caglar
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000503:physiopathology*; D000740:Anemia / Q000188:drug therapy; D001853:Bone Marrow / Q000502:physiology*; D001855:Bone Marrow Diseases / Q000503:physiopathology*; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin